Cargando…

Pharmaceutical nanotechnology: which products are been designed against COVID-19?

The current pandemic COVID-19, caused by the SARS-CoV-2 virus, has been affecting thousands of people worldwide, promoting high numbers of deaths. With this, the world population is going through a process of changing habits, with social distance, improvement of hygiene techniques, to reduce the spr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavalcanti, Iago Dillion Lima, Cajubá de Britto Lira Nogueira, Mariane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480001/
https://www.ncbi.nlm.nih.gov/pubmed/32922162
http://dx.doi.org/10.1007/s11051-020-05010-6
_version_ 1783580352214728704
author Cavalcanti, Iago Dillion Lima
Cajubá de Britto Lira Nogueira, Mariane
author_facet Cavalcanti, Iago Dillion Lima
Cajubá de Britto Lira Nogueira, Mariane
author_sort Cavalcanti, Iago Dillion Lima
collection PubMed
description The current pandemic COVID-19, caused by the SARS-CoV-2 virus, has been affecting thousands of people worldwide, promoting high numbers of deaths. With this, the world population is going through a process of changing habits, with social distance, improvement of hygiene techniques, to reduce the spread of the SARS-CoV-2 virus and, consequently, reduce the number of hospitalized people in serious condition, as well as the mortality rate. This scenario has been promoting a continuous search for researchers, in the most varied areas, for possible methods of prevention or cure. Specifically, in the field of pharmaceutical nanotechnology, a variety of products are being developed against SARS-CoV-2. Under these circumstances, we propose here an exposition of some of the nanotechnological products (nanoscale between 1 to 1000 nm) currently designed for the detection of the virus, for the prevention and treatment of COVID-19, in addition to equipment for personal protection. We believe that pharmaceutical nanotechnology will be a valuable tool in the disease from the development of products that guarantee our protection against the SARS-CoV-2 virus.
format Online
Article
Text
id pubmed-7480001
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-74800012020-09-09 Pharmaceutical nanotechnology: which products are been designed against COVID-19? Cavalcanti, Iago Dillion Lima Cajubá de Britto Lira Nogueira, Mariane J Nanopart Res Review Article The current pandemic COVID-19, caused by the SARS-CoV-2 virus, has been affecting thousands of people worldwide, promoting high numbers of deaths. With this, the world population is going through a process of changing habits, with social distance, improvement of hygiene techniques, to reduce the spread of the SARS-CoV-2 virus and, consequently, reduce the number of hospitalized people in serious condition, as well as the mortality rate. This scenario has been promoting a continuous search for researchers, in the most varied areas, for possible methods of prevention or cure. Specifically, in the field of pharmaceutical nanotechnology, a variety of products are being developed against SARS-CoV-2. Under these circumstances, we propose here an exposition of some of the nanotechnological products (nanoscale between 1 to 1000 nm) currently designed for the detection of the virus, for the prevention and treatment of COVID-19, in addition to equipment for personal protection. We believe that pharmaceutical nanotechnology will be a valuable tool in the disease from the development of products that guarantee our protection against the SARS-CoV-2 virus. Springer Netherlands 2020-09-09 2020 /pmc/articles/PMC7480001/ /pubmed/32922162 http://dx.doi.org/10.1007/s11051-020-05010-6 Text en © Springer Nature B.V. 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review Article
Cavalcanti, Iago Dillion Lima
Cajubá de Britto Lira Nogueira, Mariane
Pharmaceutical nanotechnology: which products are been designed against COVID-19?
title Pharmaceutical nanotechnology: which products are been designed against COVID-19?
title_full Pharmaceutical nanotechnology: which products are been designed against COVID-19?
title_fullStr Pharmaceutical nanotechnology: which products are been designed against COVID-19?
title_full_unstemmed Pharmaceutical nanotechnology: which products are been designed against COVID-19?
title_short Pharmaceutical nanotechnology: which products are been designed against COVID-19?
title_sort pharmaceutical nanotechnology: which products are been designed against covid-19?
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480001/
https://www.ncbi.nlm.nih.gov/pubmed/32922162
http://dx.doi.org/10.1007/s11051-020-05010-6
work_keys_str_mv AT cavalcantiiagodillionlima pharmaceuticalnanotechnologywhichproductsarebeendesignedagainstcovid19
AT cajubadebrittoliranogueiramariane pharmaceuticalnanotechnologywhichproductsarebeendesignedagainstcovid19